Healthcare in 2015 review, 2016 expectations
As 2015 winds down, this would be an opportune time to look at learnings from the last year within the healthcare industry, as well as the future insights from healthcare stakeholders. Curant Health COO, Marc O’Connor, gives his insights on developments providers, manufacturers and payers have seen this year and where future developments will take them in 2016.
Here are the top three value-based developments of healthcare in 2015:
- Sustainable growth rate (SGR) repeal
- Pharmaceuticals’ at-risk day has arrived
- Realization that new hepatitis C drugs didn’t break the system
There were numerous shifts in specialty pharmacy and healthcare, including the further erosion of the old fee-for-service model and the implementation of value-based care. This fundamental shift in the structure of how stakeholders view engaging with and treating the patient will undoubtedly continue to evolve around ways to increase the value quotient in value-based care.
Here are the top three ways to advance value-based care in 2016:
- Define value simply as outcomes divided by costs
- Support more alignment between payers and manufacturers
- Tap top value from high-cost therapies
Unwinding a healthcare system built on decades of fee-for-service delivery will not come easily. Nevertheless, 2015 saw several major healthcare changes that will enable the industry to begin to use value from innovation in technology, pharmaceuticals and clinical care as its defining metric. The value-based healthcare baby has arrived and is cutting its teeth. And while it will grow quickly, it will stumble and will need wise guidance in order to mature in a way that enables it to achieve its potential.
To read Marc’s full article on increasing value-based care for 2016, visit Managed Healthcare Executive.Tags: at-risk day, healthcare, SGR repeal, value-based healthcare